Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study

International Journal of Obesity

Volumn 29, Issue 10, 2005, Pages 1245-1251

  Salopuro, T ^a   Pulkkinen, L ^a   Lindstrom J ^b   Eriksson, J G ^b   Valle, T T ^b   Hamalainen H ^c   Ilanne Parikka, P ^d   Keinanen Kiukaanniemi S ^e,f   Tuomilehto, J ^b,g   Laakso, M ^a   Uusitupa, M ^a,h  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f OULU DEACONESS INSTITUTE   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Association; Impaired glucose tolerance; Intervention; Leptin receptor polymorphism; Type 2 diabetes

Indexed keywords

ARGININE; GLUCOSE; GLYCINE; INSULIN; LEPTIN RECEPTOR; LYSINE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DIABETIC OBESITY; FEMALE; GENE INSERTION SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE METABOLISM; HETEROZYGOSITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE EXERCISE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; RISK ASSESSMENT; WEIGHT CHANGE;

ADULT; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GENOTYPE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CELL SURFACE;

EID: 30544443607     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803024     Document Type: Article

References (31)

1. Felber JP, Golay A. Pathways from obesity to diabetes. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S39-S45.
2. Hofbauer KG. Molecular pathways to obesity. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S18-S27.
3. Ravussin E, Bouchard C. Human genomics and obesity: finding appropriate drug targets. Eur J Pharmacol 2000; 410: 131-145.
4. Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion vs impaired insulin sensitivity. Endocr Rev 1998; 19: 491-503.
5. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996; 224: 522-527.
6. Oksanen L, Kaprio J, Mustajoki P, Kontula K. A common pentanucleotide polymorphism of the 3′-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals. Int J Obes Relat Metab Disord 1998; 22: 634-640.
7. Francke S, Clement K, Dina C, Inoue H, Behn P, Vatin V, Basdevant A, Guy-Grand B, Permutt MA, Froguel P, Hager J. Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families. Hum Genet 1997; 100: 491-496.
8. Lakka HM, Oksanen L, Tuomainen TP, Kontula K, Salonen JT. The common pentanucleotide polymorphism of the 3′-untranslated region of the leptin receptor gene is associated with serum insulin levels and the risk of type 2 diabetes in non-diabetic men: a prospective case-control study. J Intern Med 2000; 248: 77-83.
9. Nishikai K, Hirose H, Ishii T, Hayashi M, Saito I, Saruta T. Effects of leptin receptor gene 3′-untranslated region polymorphism on metabolic profiles in young Japanese men. J Atheroscler Thromb 2004; 11: 73-78.
10. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997; 6: 675-679.
11. Lakka TA, Rankinen T, Weisnagel SJ, Chagnon YC, Lakka HM, Ukkola O, Boule N, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bergman R, Bouchard C. Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: The HERITAGE Family Study. Diabetes 2004; 53: 1603-1608.
12. Wauters M, Mertens I, Rankinen T, Chagnon M, Bouchard C, Van Gaal L. Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. J Clin Endocrinol Metab 2001; 86: 3227-3232.
13. Heo M, Leibel RL, Fontaine KR, Boyer BB, Chung WK, Koulu M, Karvonen MK, Pesonen U, Rissanen A, Laakso M, Uusitupa MI, Chagnon Y, Bouchard C, Donohoue PA, Burns TL, Shuldiner AR, Silver K, Andersen RE, Pedersen O, Echwald S, Sorensen TI, Behn P, Permutt MA, Jacobs KB, Elston RC, Hoffman DJ, Gropp E, Allison DB. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord 2002; 26: 640-646.
14. Echwald SM, Sorensen TD, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Chung WK, Leibel RL, Pedersen O. Amino acid variants in the human leptin receptor: lack of association to juvenile onset obesity. Biochem Biophys Res Commun 1997; 233: 248-252.
15. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 2001; 86: 4434-4439.
16. Gotoda T, Manning BS, Goldstone AP, Imrie H, Evans AL, Strosberg AD, McKeigue PM, Scott J, Aitman TJ. Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet 1997; 6: 869-876.
17. Wauters M, Considine RV, Chagnon M, Mertens I, Rankinen T, Bouchard C, Van Gaal LF. Leptin levels, leptin receptor gene polymorphisms, and energy metabolism in women. Obes Res 2002; 10: 394-400.
18. Takahashi-Yasuno A, Masuzaki H, Miyawaki T, Matsuoka N, Ogawa Y, Hayashi T, Hosoda K, Yoshimasa Y, Inoue G, Nakao K. Association of Ob-R gene polymorphism and insulin resistance in Japanese men. Metabolism 2004; 53: 650-654.
19. Chiu KC, Chu A, Chuang LM, Saad MF. Association of leptin receptor polymorphism with insulin resistance. Eur J Endocrinol 2004; 150: 725-729.
20. Stefan N, Vozarova B, Del Parigi A, Ossowski V, Thompson DB, Hanson RL, Ravussin E, Tataranni PA. The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord 2002; 26: 1629-1632.
21. Chagnon YC, Wilmore JH, Borecki IB, Gagnon J, Perusse L, Chagnon M, Collier GR, Leon AS, Skinner JS, Rao DC, Bouchard C. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 2000; 85: 29-34.
22. Mattevi VS, Zembrzuski VM, Hutz MH. Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 2002; 26: 1179-1185.
23. Wauters M, Mertens I, Chagnon M, Rankinen T, Considine RV, Chagnon YC, Van Gaal LF, Bouchard C. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001; 25: 714-720.
24. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 2001; 108: 233-236.
25. Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, Tuomilehto J. The Finnish Diabetes Prevention Study. Br J Nutr 2000; 83 (Suppl 1): S137-S142.
26. Eriksson J, Lindström J, Valle T, Aunola S, Hämälä inen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42: 793-801.
27. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
28. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 1507-1511.
29. Ilanne-Parikka P, Eriksson JG, Lindström J, Hämälä inen H, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J. Prevalence of the metabolic syndrome and its components: findings from a finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-2140.
30. van Rossum CT, Hoebee B, van Baak MA, Mars M, Saris WH, Seidell JC. Genetic variation in the leptin receptor gene, leptin, and weight gain in young Dutch adults. Obes Res 2003; 11: 377-386.
31. Ukkola O, Tremblay A, Despres JP, Chagnon YC, Campfield LA, Bouchard C. Leptin receptor Gln223Arg variant is associated with a cluster of metabolic abnormalities in response to long-term overfeeding. J Intern Med 2000; 248: 435-439.